Literature DB >> 2056335

Exacerbation of myasthenia by propafenone.

B R Lecky, D Weir, E Chong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2056335      PMCID： PMC488508          DOI： 10.1136/jnnp.54.4.377

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  2 in total

1.  Myasthenia-like syndrome induced by cardiovascular agents. Report of a case.

Authors:  B Fierro; M G Castiglione; G Salemi; G Savettieri
Journal:  Ital J Neurol Sci       Date:  1987-04

2.  Food allergy in migraine. Study of dietary exclusion and RAST.

Authors:  J Monro; J Brostoff; C Carini; K Zilkha
Journal:  Lancet       Date:  1980-07-05       Impact factor: 79.321
  2 in total
  2 in total

Review 1.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 2.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.